Compounds > androstenediol
Page last updated: 2024-08-21

androstenediol and Adenocarcinoma

androstenediol has been researched along with Adenocarcinoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beranek, PA; Bonney, RC; James, VH; Jones, DL; Reed, MJ; Scanlon, MJ1
Bird, CE; Clark, AF; Masters, V; Sterns, EE1
Jelić, S; Nikolić-Tomasević, Z; Popov, I; Radosavljević, D1
Bélanger, A; Brochu, M; Cusan, L; Dupont, A; Labrie, F1

Other Studies

4 other study(ies) available for androstenediol and Adenocarcinoma

ArticleYear
Adrenal androgen concentrations in breast tumours and in normal breast tissue. The relationship to oestradiol metabolism.
    Journal of steroid biochemistry, 1984, Volume: 20, Issue:1

    Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Adult; Aged; Androstenediol; Androstenediols; Breast; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Radioimmunoassay

1984
Effects of aminoglutethimide on delta 5-androstenediol metabolism in postmenopausal women with breast cancer.
    Cancer research, 1982, Volume: 42, Issue:11

    Topics: Adenocarcinoma; Adult; Aminoglutethimide; Androstenediol; Androstenediols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Hydrocortisone; Kinetics; Menopause; Metabolic Clearance Rate; Middle Aged

1982
Androgen level variations, clinical response to LHRH agonists and changes in the quality of life subscales in metastatic prostate cancer--speculations about possible role of the monoamine system.
    Neoplasma, 1997, Volume: 44, Issue:5

    Topics: Acid Phosphatase; Adenocarcinoma; Aged; Alkaline Phosphatase; Androstenediol; Antineoplastic Agents, Hormonal; Bone Neoplasms; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Testosterone

1997
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1988, Volume: 11, Issue:5

    Topics: Adenocarcinoma; Adrenal Cortex Hormones; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dehydroepiandrosterone; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Kinetics; Luteinizing Hormone; Male; Pregnenolone; Progesterone; Prolactin; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate

1988